Ageless vs MEDGm

FDAWarning letter issued to Lovely Meds, Inc. dba Lovely Meds in September 2025. Try Ageless's own medical-oversight page identifies Lovely Meds, Inc. as the company that operates tryageless.com. The letter concerns lovelymeds.com, does not name tryageless.com, and FDA has not closed it out. See the FDA warning-letter database.

Strengths

• +Unusually broad compounded menu — GLP-1, NAD+, sermorelin, TRT, LDN and more, in both injectable and oral formats
• +Every GLP-1 format has a real month-to-month rung as well as prepay tiers, so nobody is forced into a commitment in order to buy at all
• +Sublingual tirzepatide drops are genuinely cheaper than the injection without a commitment — $199/mo month-to-month against $349 for the shot
• +The SLIM50 code is stated as a recurring $50 discount rather than a first-month teaser that expires
• +Fully online: licensed-clinician review and discreet delivery, with upfront compounded/not-FDA disclosures

Where it loses points

• –The advertised entry prices are twelve-month rungs, not monthly rates: the hero's "from $159/mo" and the "FROM $199 / $249" cards are annual plans charged as one payment of $1,908, $2,388 or $2,988 — buying by the month costs $279 for semaglutide and $349 for tirzepatide
• –The same company sells the same semaglutide injection at two prices — a storefront catalog at $119–$229 for a month's supply as a one-time purchase, and the plan page our link resolves to at $279/mo — with no page reconciling them, and the storefront's checkout is disabled so its figures are never actually charged
• –The storefront disagrees with itself as well: for the same item its struck-through "was" anchor is $169 in one place and $229 in another
• –Sermorelin is priced four different ways across the company's own pages ($189, $126, $239–$289, $199–$299), so a figure read off one of them is not the figure the funnel charges
• –The default variant on a product page is the LOWEST dose, so any "from" price is the bottom of a dose ladder that runs up to $199–$299
• –TRT has no month-to-month rung at all — the shortest purchasable term is a three-month prepay, from $387 charged up front
• –Everything is compounded and not FDA-approved — not equivalent to brand Wegovy/Ozempic/Zepbound
• –Oral GLP-1 drops and troches lack robust absorption/efficacy evidence versus injectables
• –No published state-availability list, so coverage is only settled inside the funnel

Strengths

• +Names four dispensing pharmacies with street addresses and phone numbers
• +States its compounding class — produced in state-licensed 503A or FDA-registered facilities — rather than leaving it unsaid
• +Coverage is 50 states plus the District of Columbia and the intake's own state selector agrees with the Terms, which is rarer than it should be
• +Refills and shipping are described as included, with no separate shipping line at checkout
• +Prices an oral semaglutide lane alongside both injections

Where it loses points

• –No price is visible until a sixteen-screen quiz ending in name, email and phone number has been completed
• –$179 and $279 are first-month rates produced by an auto-applied coupon; the standing month-to-month rates are $299 and $399
• –The treatments FAQ says “your price never increases, even as your dose goes up” on a plan whose price increases at the first renewal
• –The twelve-month bundle auto-renews for another full upfront charge of $2,028 or $3,228, billed up to ten days early, and nothing is refundable once taken
• –The funnel prints “prescription plan approved” and a 100% success probability before any payment and before a clinician has seen the intake, beside a twenty-minute timer that resets on reload
• –Zepbound, Wegovy and Ozempic have cards on the GLP-1 page and all six links lead to the quiz; the post-intake funnel contains none of those names
• –No principal place of business is published — only a Delaware state of formation
• –No clinician is named and no NPI appears anywhere; the site names professional entities only